DEVELOPMENT OF LIPID-BASED VESICLES OF TERBINAFINE GEL FOR SKIN DELIVERY BY 32FULL FACTORIAL DESIGN
DOI:
https://doi.org/10.22159/ijap.2024v16i4.50460Keywords:
Ethosomes, Terbinafine hydrochloride, Optimization, Anti-fungal, Transdermal enhancementAbstract
Objective: Terbinafine is a poorly water-soluble and highly permeable allylamine antifungal (BCS-II) drug. In this study, we looked at the possibility of using ethosomes as vesicular lipid nanocarriers to enhance the transdermal delivery of terbinafine.
Methods: Using a 32 full factorial design, the ethosomal formulation with different soya lecithin and cholesterol concentrations was improved and optimized. The influence of independent variables, namely soya lecithin and cholesterol concentration in ethosomes was determined by estimating dependent variable including the particle size, polydispersity index, zeta potential, entrapment efficiency, and in vitro drug release. To improve the residence time of ethosomes on the topical application, the ethosomes were incorporated into the carbopol gel. 1% w/v of Carbopol 934 P gel-embedded Terbinafine ethosomes were used to study medication release and skin interactions.
Results: Optimized ratios of soya lecithin and cholestrol was used to prepare vesicles. Formulation had a particle size of 1207.39±2.71 nm, entrapment efficiency of 94.46±0.47%, and in vitro diffusion of 51.27±0.16%. It was found that the growth of fungus Aspergillus niger and Candida albicans were inhibited by Ethosomal Gel. However, ethosomal gel had more inhibitory activity on Apergillus niger compared to positive control.
Conclusion: The current study suggests that ethosomal vesicles may improve transdermal dispersion without causing skin irritation. Terbinafine-loaded ethosomes have the potential to be one of the most important transdermal application techniques for the treatment of fungi-related disorders.
Downloads
References
Alkhalidi HM, Hosny KM, Rizg WY. Oral gel loaded by fluconazole-sesame oil nanotransfersomes: development, optimization, and assessment of antifungal activity. Pharmaceutics. 2020;13(1):1-23. doi: 10.3390/pharmaceutics13010027. doi: 10.3390/pharmaceutics13010027, PMID 33375740.
Saifee M, Atre M, Toshniwal R. Formulation and in vitro evaluation of ethosomal gel of repaglinide for transdermal delivery. Int J Pharm Phytopharm Res. 2021;11(4):11-7. doi: 10.51847/lQKgwgUi1l.
Akhtar N, Akhtar N, Menaa F, Alharbi W, Alaryani FS, Alqahtani AM. Fabrication of ethosomes containing tocopherol acetate to enhance transdermal permeation: in vitro and ex vivo characterizations. Gels. 2022;8(6):1-18. doi: 10.3390/gels8060335, PMID 35735679.
Ivaturi Bala T, Sireesha K, Malavika B. Development of efinaconazole nail gel for the treatment of onchomycosis. Int J Appl Pharm. 2024;16(2):1-11. doi: 10.17605/OSF. IO/9P4S6.
Agarwal S, Gautam G. Formulation development and characterization of ethosomes of atorvastatin. Int Res J Pharm. 2019;10(7):131-6. doi: 10.7897/2230-8407.1007232.
Hassan DH, Shohdy JN, El-Nabarawi MA, El-Setouhy DA, Abdellatif MM. Nanostructured lipid carriers for transdermal drug delivery. Int J App Pharm. 2022;14(4):88-93. doi: 10.22159/ijap.2022v14i4.44564.
Nainwal N, Jawla S, Singh R, Saharan VA. Transdermal applications of ethosomes-a detailed review. J Liposome Res. 2019;29(2):103-13. doi: 10.1080/08982104.2018.1517160, PMID 30156120.
Giri M, Bhalke R. Formulation and evaluation of topical anti-inflammatory herbal gel. Asi J Pharm Clin Res. 2019;12(7):252-5. doi: 10.22159/ajpcr.2019.v12i7.33859.
Nainwal N, Jawla S, Singh R, Saharan VA. Transdermal applications of ethosomes-a detailed review. J Liposome Res. 2019;29(2):103-13. doi: 10.1080/08982104.2018.1517160, PMID 30156120.
Ansari SA, Qadir A, Warsi MH, Mujeeb M, Aqil M, Mir SR. Ethosomes-based gel formulation of karanjin for treatment of acne vulgaris: in vitro investigations and preclinical assessment. 3 Biotech. 2021;11(11):456. doi: 10.1007/s13205-021-02978-3, PMID 34631355.
Zahid SR, Upmanyu N, Dangi S, Ray SK, Jain P, Parkhe G. Ethosome: a novel vesicular carrier for transdermal drug delivery. J Drug Delivery Ther. 2018;8(6):318-26. doi: 10.22270/jddt.v8i6.2028.
Garg BJ, Garg NK, Beg S, Singh B, Katare OP. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target. 2016;24(3):233-46. doi: 10.3109/1061186X.2015.1070855, PMID 26267289.
Akhtar N, Pathak K. Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel. AAPS PharmSciTech. 2012;13(1):344-55. doi: 10.1208/s12249-012-9754-y, PMID 22282041.
Bolla PK, Clark BA, Juluri A, Cheruvu HS, Renukuntla J. Evaluation of formulation parameters on permeation of ibuprofen from topical formulations using Strat-M® membrane. Pharmaceutics. 2020;12(2):151-70. doi: 10.3390/pharmaceutics12020151, PMID 32069850.
Thavva V, Baratam SR. Formulation and evaluation of terbinafine hydrochloride microsponge gel. Int J App Pharm. 2019;11(6):78-85. doi: 10.22159/ijap.2019v11i6.32502.
Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: a review. Biomater Res. 2021;25(1):24. doi: 10.1186/s40824-021-00226-6, PMID 34321111.
El-Shenawy AA, Abdelhafez WA, Ismail A, Kassem AA. Formulation and characterization of nanosized ethosomal formulations of antigout model drug (febuxostat) prepared by cold method: in vitro/ex vivo and in vivo assessment. AAPS PharmSciTech. 2019;21(1):31. doi: 10.1208/s12249-019-1556-z, PMID 31858305.
Eng N Supraja, Krishna Sailaja A. Formulation of mefenamic acid loaded ethosomal gel by hot and cold methods. Nano Biomed Eng. 2017;9:27-35. doi: 10.5101/nbe.v9i1.
Shaghlil L, Alshishani A, Sa’aleek AA, Abdelkader H, Al-ebini Y. Formulation and evaluation of nasal insert for nose-to-brain drug delivery of rivastigmine tartrate. J Drug Deliv Sci Technol. 2022;76. doi: 10.1016/j.jddst.2022.103736.
Jain PS, Chaudhari AJ, Patel SA, Patel ZN, Patel DT. Development and validation of the UV-spectrophotometric method for determination of terbinafine hydrochloride in bulk and in formulation. Pharm Methods. 2011;2(3):198-202. doi: 10.4103/2229-4708.90364, PMID 23781456.
Anju K, Priya S, Sandeep DS, Nayak P, Kumar P, Kumar A. Formulation and optimization of zaltoprofen loaded ethosomal gel by using 23 full factorial designs. J Pharm Res Int. 2021;33(24B):30-44. doi: 10.9734/jpri/2021/v33i24B31439.
Jain S, Tiwary AK, Sapra B, Jain NK. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech. 2007;8(4):E111. doi: 10.1208/pt0804111, PMID 18181532.
Peram MR, Jalalpure S, Kumbar V, Patil S, Joshi S, Bhat K. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation. J Liposome Res. 2019;29(3):291-311. doi: 10.1080/08982104.2018.1556292, PMID 30526186.
Hajare A, Dol H, Patil K. Design and development of terbinafine hydrochloride ethosomal gel for enhancement of transdermal delivery: in vitro, in vivo, molecular docking, and stability study. J Drug Deliv Sci Technol. 2021;61. doi: 10.1016/j.jddst.2020.102280.
Celebi N, Ermis S, Ozkan S. Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity. Drug Dev Ind Pharm. 2015;41(4):631-9. doi: 10.3109/03639045.2014.891129, PMID 24576265.
Alastruey Izquierdo A, Melhem MS, Bonfietti LX, Rodriguez Tudela JL. Susceptibility test for fungi: clinical and laboratorial correlations in medical mycology. Rev Inst Med Trop S Paulo. 2015;57Suppl 19:57-64. doi: 10.1590/S0036-46652015000700011.
Ramage G, lopez Rib JL. Techniques for antifungal susceptibility testing of candida albicans biofilms. In: Ernst EJ, Rogers PD, editors. Antifungal agents. Methods in molecular Medicine™. Humana Press; 2005;118. doi: 10.1385/1-59259-943-5:071.
Niu XQ, Zhang DP, Bian Q, Feng XF, Li H, Rao YF. Mechanism investigation of ethosomes transdermal permeation. Int J Pharm X. 2019;1:100027. doi: 10.1016/j.ijpx.2019.100027, PMID 31517292.
Paolino D, lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106(1-2):99-110. doi: 10.1016/j.jconrel.2005.04.007, PMID 15935505.
Kaur M, Singh K, Jain SK. Luliconazole vesicular-based gel formulations for its enhanced topical delivery. J Liposome Res. 2020;30(4):388-406. doi: 10.1080/08982104.2019.1682602, PMID 31631734.
Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv. 2009;6(8):813-25. doi: 10.1517/17425240903071029, PMID 19569979.
Pathan IB, Jaware BP, Shelke S, Ambekar W. Curcumin loaded ethosomes for transdermal application: formulation, optimization, in vitro and in vivo study. J Drug Deliv Sci Technol. 2018;44:49-57. doi: 10.1016/j.jddst.2017.11.005.
Selvamuthukumar R, Murali R, Srinivasan N, Mohankumar A, Panicker N. Formulation development and evaluation of immediate release tablet of terbinafine hydrochloride. Res J Pharm Technol. 2020;13(10):4648-54. doi: 10.5958/0974-360X.2020.00818.5.
Anggraini YE, Trisnowati N, Martien R, Danarti R. A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol. Trials. 2024;25(1):12. doi: 10.1186/s13063-023-07880-2, PMID 38167064.
Mahaparale PR, Ikam SA, Chavan MS. Development and evaluation of terbinafine hydrochloride polymeric microsponges for topical drug delivery. Ind J Pharm Sci. 2018;80(6). doi: 10.4172/pharmaceutical-sciences.1000459.
Shamma RN, Elsayed I. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res. 2013;23(3):244-54. doi: 10.3109/08982104.2013.801489, PMID 23713516.
Maha HL, Sinaga KR, Sinaga KR, Masfria M, Masfria M. Formulation and evaluation of miconazole nitrate nanoemulsion and cream. Asian J Pharm Clin Res. 2018;11(3). doi: 10.22159/ajpcr.2018.v11i3.22056.
Pawar HA, Attarde VB, Parag Subhash G. Optimization of bifonazole-loaded nisomal formulation using plackett-burman design and 2 factorial design. Open Pharmaceutical Sciences J. 2016;3(1):31-48. doi: 10.2174/1874844901603010031.
Vaghasiya H, Kumar A, Sawant K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 2013;49(2):311-22. doi: 10.1016/j.ejps.2013.03.013, PMID 23557842.
Khan R, Saif Dr, Naureen H, Sarwar A, Shahbaz M, Arif M. Formulation and evaluation of metronidazole loaded nanosponges for topical delivery. Pharm Com. 2022;1:71-87. doi: 10.55627/pharma.001.001.0185.
Shen LN, Zhang YT, Wang Q, Xu L, Feng NP. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014;460(1-2):280-8. doi: 10.1016/j.ijpharm.2013.11.017, PMID 24269286.
Published
How to Cite
Issue
Section
Copyright (c) 2024 T. S. SARASWATHI, R. ROSHINI, N. DAMODHARAN, M. MOTHILAL, S. K. JANANI
This work is licensed under a Creative Commons Attribution 4.0 International License.
